Skip to main content
Quest Diagnostics

Drug Monitoring Webinar: Contributing Factors into the Skyrocketing Drug Misuse Epidemic in the US

On-Demand Webinar

Presented by Dr Jack Kain and moderated by Dr Jeff Gudin

 

The objectives of this webinar include:

 

  • Hear results from the recent Quest Diagnostics Health Trends report which combines data from a Harris Poll survey of over 500 primary care physicians, with results of clinical drug laboratory testing performed by Quest Diagnostics across the US

 

  • Gain a deeper understanding of the contributing factors to the significant surge in drug overdose deaths that we have seen in the US

 

  • Learn about barriers health professionals face in their ability to monitor and intervene with their patients at risk for drug misuse

 

 

Date:
Mar 30, 2022
Location:
Virtual
Presenter(s):
Jack Kain, PharmD
Moderator(s):
Jeff Gudin

Related content

On-Demand Webinar
Current state of Pharmacogenomics and its future
Test FAQ
Novel Psychoactive Substances (NPS) Panel
Test FAQ
Drug monitoring, Phoshatidylethanol (PEth), Blood Test

Jack Kain, PharmD

Jeff Gudin, MD

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.